Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Haatch Ventures
Haatch EIS Fund
9th Apr 2026
2025 Pharma Statistics
8th Apr 2026
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
131: Using AI and YouTube in a VC investment process | Johnathan Matlock of Empirical Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Ranked at number 4 in FeedSpot Podcasts for '10 Best Venture Capital Podcasts UK Edition 2026' -
Leading podcast in EIS
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Surface Transforms
Rapid acceleration – “game-change” announcements
By
Mike Foster
05 Sep 2019
The Monthly: September 2019
03 Sep 2019
Shield Therapeutics Plc
Life Sciences
FDA approval ushers in a new era for Shield
02 Sep 2019
Non-Standard Finance
Financials
“Now is the time for profit”
By
Mark Thomas
29 Aug 2019
Real Estate Credit Investments (RECI)
Financials
7%+ yield from well-secured property debt portfolio
By
Mark Thomas
28 Aug 2019
Artificial Solutions
Technology
2Q’19 results – customer wins, accelerating order intake
By
Milan Radia
22 Aug 2019
Phoenix Copper Ltd
Mining
First stage in potential world-class copper mine
By
Paul Mylchreest
22 Aug 2019
Advanced Oncotherapy
Life Sciences
Nearing the end-goal
By
Dr Martin Hall
08 Aug 2019
Primary Health Properties
Property
High security and accelerating dividend growth
By
Mike Foster
05 Aug 2019
Shield Therapeutics Plc
Life Sciences
FDA approval opens door to major US opportunity
05 Aug 2019
Burford Capital
Financials
Results don’t need to be appealed
By
Dr Brian Moretta
05 Aug 2019
Prev
1
...
58
59
60
61
62
...
90
Next
